Nucleic acid molecules that inhibit mRNA expression via RNAi and their applications

TW202639854APending Publication Date: 2026-10-01CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114152305
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-17
Filing Date
2025-12-31
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078929_001
    Figure TWG2TA001078929_001
  • Figure TWG2TA001078929_002
    Figure TWG2TA001078929_002
  • Figure TWG2TA001078929_003
    Figure TWG2TA001078929_003
Patent Text Reader

Abstract

This invention provides a double-stranded RNA (dsRNA) molecule that inhibits the expression of target genes through RNAi and its applications, and specifically provides modification schemes for the sense and antisense strands of dsRNA.
Need to check novelty before this filing date? Find Prior Art